Group items tagged

As the first new Lupus drug to debut in the last half-of-a-century, Benlysta has the potential to be something special. Reception of the drug from doctors has been lukewarm thus far, but with many other treatments associated with severe potential side effects, Benlysta may be a blockbuster nonetheless.

Tech stocks closed the day on a mixed note after Apple reached its all-time high in midday trading and Netflix continues to shed shares following the decision to divide its streaming and hardcopy DVD businesses.